Full-Time

Document Control Specialist

Confirmed live in the last 24 hours

ProKidney

ProKidney

201-500 employees

Develops cell therapy for chronic kidney disease

No salary listed

Entry, Junior

Winston-Salem, NC, USA

Category
Lab & Research
Life Sciences
Medical Research
Requirements
  • 0 - 2 years of relevant hands-on document management experience.
  • Associates degree from an accredited college or university or a combination of equivalent education and applicable job experience.
  • Demonstrate understanding of cGMP, GDP, and QMS.
  • Ability to learn and understand technical aspects within documentation.
  • Ability to maintain positive cross-functional and collaborative relationships.
  • Ability to maintain a positive attitude and ability to perform under pressure.
  • Ability to exercise judgment within defined practices and policies in performing document control functions with input from supervisor.
  • Must be highly organized.
  • Must be a team player.
  • Demonstrated ability to problem solve.
  • Strong communication skills, including both verbal and written.
Responsibilities
  • Ensure that controlled documentation supporting GxP operations is formatted, current, accurate, and processed in a timely manner.
  • Provide guidance to Manufacturing and Quality personnel as it relates to GMP/in plant GMP documentation.
  • Perform routine and ad hoc document control metric reporting and analysis.
  • Identify continuous improvement opportunities.
  • Participate in problem solving meetings.
  • Oversee issuance and storage of controlled documents.
  • Manage, organize, and maintain all Quality document storage of controlled documentation.
  • Provide copies of controlled documents to ProKidney staff on an as needed basis.
  • Provide timely and accurate, right the first time GMP document review.
  • Support internal and external audits and regulatory inspections.
  • Review and identify documentation discrepancies.
  • Collaborate with internal resources to efficiently and effectively resolve documentation related issues.
  • Initiate and/or assist with quality records in Quality Management System (QMS) as needed.
  • Scan and enter documentation into Quality Management Systems (MasterControl) as directed.
  • Assist and comply with Quality Assurance documentation functions.
  • Adhere to internal/external guidelines, specifications, and regulatory requirements while reviewing documentation.
  • Comply with company policies and procedures.

ProKidney focuses on treating Chronic Kidney Disease (CKD) through a unique cell therapy called rilparencel. This therapy aims to preserve kidney function in patients with advanced CKD, potentially delaying or eliminating the need for dialysis, which many patients currently rely on. ProKidney targets a significant healthcare issue, as over 35 million adults in the U.S. are affected by CKD, with many progressing to dialysis each year. The company is in the late stages of clinical trials for rilparencel, which has shown promise in maintaining kidney function. Unlike competitors, ProKidney is dedicated to a specific and underserved segment of the healthcare market, focusing solely on CKD treatment. The goal is to provide a viable alternative to dialysis, improving the quality of life for millions of patients.

Company Size

201-500

Company Stage

IPO

Headquarters

Winston-Salem, North Carolina

Founded

2015

Simplify Jobs

Simplify's Take

What believers are saying

  • ProKidney raised $140 million, boosting clinical trials and R&D for rilparencel.
  • The FDA's approval of similar therapies may ease rilparencel's regulatory pathway.
  • Growing personalized medicine trends favor ProKidney's cell therapy approach.

What critics are saying

  • ProKidney's canceled Greensboro expansion may harm its reputation and stakeholder trust.
  • Increased manufacturing expenses could strain financial resources, affecting development pace.
  • Reliance on public offerings for capital may indicate potential cash flow issues.

What makes ProKidney unique

  • ProKidney is pioneering rilparencel, a novel cell therapy for CKD.
  • Rilparencel aims to delay or eliminate the need for dialysis in CKD patients.
  • ProKidney targets an underserved CKD market, addressing a critical treatment gap.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-4%

2 year growth

-4%
Stock Titan
Jan 7th, 2025
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference

WINSTON-SALEM, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) - ProKidney Corp. (Nasdaq: PROK) ("ProKidney"), a late clinical-stage biotech company focused on the development of a first-in-class cell therapy candidate for chronic kidney disease (CKD), today announced that ProKidney's CEO, Bruce Culleton, M.D., will present at the 43rd Annual J.P. Morgan Healthcare Conference.

Rhino Times
Nov 25th, 2024
The Best Laid Plans Of Mice And ProKidney...

In June 2023, ProKidney announced that the company planned to invest $485 million in a Greensboro biomedical factory that would create roughly 330 jobs - with those jobs averaging just under $75,000 a year.

Business North Carolina
Nov 22nd, 2024
ProKidney buys Winston-Salem land after passing on Greensboro deal

ProKidney's purchasing the buildings from Breit SE Industrial Propco, also known as Blackstone Real Estate Income Trust.

WFMY News 2
Nov 19th, 2024
ProKidney no longer coming to Greensboro, Chamber of Commerce confirms

ProKidney had previously planned to expand operations into Greensboro.

Bizjournals
Oct 23rd, 2024
Power 50 Five to Watch: Bruce Culleton, ProKidney

Less than six months after joining the company, Dr. Bruce Culleton was appointed CEO of ProKidney, a regenerative medicine that made one of the largest manufacturing investments in Triad history.